Is There a Need to Add Another Dimension (Time) to the Evaluation of the Arrhythmogenic Potential of New Drug Candidates in Vitro?

Circulation - United States
doi 10.1161/circulationaha.114.010819
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Application of in Vitro Models in a Preclinical Safety Evaluation of New Drug Candidates

Farmacja Polska
2018English

Roquin Paralogs Add a New Dimension to ICOS Regulation

Immunity
Infectious DiseasesAllergyImmunology
2013English

Is There a Need to Identify New Anti-Emetic Drugs?

Drug Discovery Today: Therapeutic Strategies
2007English

Is There a Need to Redefine the Upper Normal Limit of TSH?

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

In Vitro Evaluation of the Drug Interaction Potential of Doravirine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Through to Another Dimension

Nature
Multidisciplinary
1984English

In Vitro Assessment of the Neuroprotective and Antioxidant Properties of New Benzimidazole Derivatives as Potential Drug Candidates for the Treatment of Parkinson’s Disease

Proceedings
2019English

Is Conceiving a Child to Benefit Another Against the Interests of the New Child?

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2005English

In Vitro Interactions Between New Antitubercular Drug Candidates SQ109 and TMC207

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy